Recommendations for Essential Esophageal Physiologic Testing During the COVID-19 Pandemic

Yeong Yeh Lee; Albert J. Bredenoord; C. Prakash Gyawali

doi:10.1016/j.cgh.2020.04.075

Recommendations for Essential Esophageal Physiologic Testing During the COVID-19 Pandemic

Yeong Yeh Lee, Albert J. Bredenoord, C. Prakash Gyawali

Division of Gastroenterology

Research output: Contribution to journal › Article › peer-review

9 Scopus citations

Original language	English
Pages (from-to)	1906-1908
Number of pages	3
Journal	Clinical Gastroenterology and Hepatology
Volume	18
Issue number	9
DOIs	https://doi.org/10.1016/j.cgh.2020.04.075
State	Published - Aug 2020

Keywords

Ambulatory Reflux Monitoring
COVID-19
Esophageal Manometry

Access to Document

10.1016/j.cgh.2020.04.075

Cite this

@article{d38bf7caf9b3459c9e233c7b79204cbe,

title = "Recommendations for Essential Esophageal Physiologic Testing During the COVID-19 Pandemic",

keywords = "Ambulatory Reflux Monitoring, COVID-19, Esophageal Manometry",

author = "Lee, {Yeong Yeh} and Bredenoord, {Albert J.} and Gyawali, {C. Prakash}",

note = "Funding Information: Conflicts of interest These authors disclose the following: Albert J. Bredenoord has received research funding from Nutricia, Norgine, and Bayer; and received speaker and/or consulting fees from Laborie, EsoCap, Diversatek, Medtronic, Dr. Falk Pharma, Calypso Biotech, Thelial, Robarts, Reckett Benkiser, Regeneron, Celgene, Bayer, Norgine, AstraZeneca, Almirall, Arena, and Allergan. C. Prakash Gyawali has served as a consultant for Ironwood, Torax, Quintiles, Medtronic, and Diversatek. The remaining author discloses no conflicts.",

year = "2020",

month = aug,

doi = "10.1016/j.cgh.2020.04.075",

language = "English",

volume = "18",

pages = "1906--1908",

journal = "Clinical Gastroenterology and Hepatology",

issn = "1542-3565",

number = "9",

}

TY - JOUR

T1 - Recommendations for Essential Esophageal Physiologic Testing During the COVID-19 Pandemic

AU - Lee, Yeong Yeh

AU - Bredenoord, Albert J.

AU - Gyawali, C. Prakash

N1 - Funding Information: Conflicts of interest These authors disclose the following: Albert J. Bredenoord has received research funding from Nutricia, Norgine, and Bayer; and received speaker and/or consulting fees from Laborie, EsoCap, Diversatek, Medtronic, Dr. Falk Pharma, Calypso Biotech, Thelial, Robarts, Reckett Benkiser, Regeneron, Celgene, Bayer, Norgine, AstraZeneca, Almirall, Arena, and Allergan. C. Prakash Gyawali has served as a consultant for Ironwood, Torax, Quintiles, Medtronic, and Diversatek. The remaining author discloses no conflicts.

PY - 2020/8

Y1 - 2020/8

KW - Ambulatory Reflux Monitoring

KW - COVID-19

KW - Esophageal Manometry

UR - http://www.scopus.com/inward/record.url?scp=85084616845&partnerID=8YFLogxK

U2 - 10.1016/j.cgh.2020.04.075

DO - 10.1016/j.cgh.2020.04.075

M3 - Article

C2 - 32371164

AN - SCOPUS:85084616845

SN - 1542-3565

VL - 18

SP - 1906

EP - 1908

JO - Clinical Gastroenterology and Hepatology

JF - Clinical Gastroenterology and Hepatology

IS - 9

ER -

Recommendations for Essential Esophageal Physiologic Testing During the COVID-19 Pandemic

Keywords

Access to Document

Other files and links

Cite this